Opinion: Genome sequencing can lead to life-changing care for infants. California should make it more available on April 14, 2021 Media Coverage News Innovative medical technology is constantly being developed, and with it comes the possibility for incredible breakthroughs in modern medicine. California has never seen scientific advancements within closer reach than they are today. For critically ill infants hospitalized with unexplained rare diseases, the opportunity to benefit from a medical miracle has arrived.
Rapid Genome Sequencing Can Save Babies With Rare Diseases, If They Can Get It on March 31, 2021 Media Coverage News Undiagnosed genetic diseases take a serious physical and emotional toll on families. Rapid genome sequencing can provide answers and guide treatment decisions, but so far, insurance companies have been reluctant to pay. That’s beginning to change.
AdventHealth diagnoses severely underweight baby with rare allergy using genomic testing on February 19, 2021 Media Coverage News A Central Florida family is thanking AdventHealth and genomic testing for a life-saving diagnosis that saved their baby boy. Six months ago, when Michael Ferrara-Urban was three-months-old, he was admitted to AdventHealth for Children (AHFC) for “failure to thrive.” Last April, AHFC partnered with Rady Children’s Institute for Genomic Medicine in San Diego to bring the quickest turnaround for genomic test results in the country, to Central Florida for the first time.
Global Genes forges rare-disease support network partnership on October 22, 2020 Media Coverage News Global Genes will work with Rady Children’s Institute for Genomic Medicine (RCIGM) to develop a support network designed to help patients and families dealing with gene-based rare diseases. The collaboration aims to help shorten the path to accurate diagnoses, and reduce the gap in service and support for such diseases.
Inside Our Child’s Battle With Mitochondrial Disease on October 20, 2020 Media Coverage News “Despite a beautiful pregnancy and delivery with every prenatal screening and precaution taken, Evan was born with mitochondrial disease.” Lindzi Scharf shares a personal essay on Variety.com about her family’s diagnostic odyssey and how RCIGM offered a break-through diagnosis and, just as importantly, a personal touch.
Rady Children’s Hospital reports double win, saving babies and cash on June 18, 2020 Media Coverage News A pilot project aimed at extending rapid DNA-based diagnosis to infants with severe, but unexplained symptoms found answers for 76 different families across five California hospitals, according to a new report to be released by Rady Children’s Hospital today.
Plan Will Cover Whole Genome Sequencing for Ill Children on April 9, 2020 Media Coverage News Blue Shield of California has agreed to cover rapid and ultra-rapid whole genome sequencing for critically ill infants and children in intensive care who have unexplained medical conditions. The agreement — which will use testing at Rady Children’s Institute for Genomic Medicine, a center of excellence in genetic testing — likely will spur additional insurers to add coverage for this diagnostic technology, observers say
Rady Lands $2 Million Pilot that Could Bring High-End Genetic Diagnosis to Kids on Medi-Cal on October 15, 2018 Media Coverage News Daily vitamin doses were all that 11-month-old Maverick Coltrin needed to end the deadly seizures that arrived shortly after his birth. But that simple solution materialized only after quick-turnaround genetic sequencing helped doctors at Rady Children’s Hospital in San Diego find the correct diagnosis fast enough to make a difference for the rapidly-deteriorating infant.
Sequencing Has Greater Diagnostic, Clinical Utility Than Microarrays for Pediatric Genetic Disease on October 15, 2018 Media Coverage News Whole-genome and whole-exome sequencing have greater diagnostic and clinical utility than chromosomal microarrays in children thought to have a genetic disease, according to a new analysis. This suggested to the Children’s Institute for Genomic Medicine-led research team that sequencing should be considered a first-line genomic test.
Children’s Genomics Partnership to Boost Treatment on October 15, 2018 Media Coverage News A superteam of seven pediatric hospitals with advanced genetic and genomic testing capabilities is reporting progress in their efforts to improve the diagnosis of rare childhood diseases and hasten treatment.